Medigus Ltd. (MDGS): Price and Financial Metrics
MDGS Price/Volume Stats
| Current price | $4.80 | 52-week high | $13.05 |
| Prev. close | $4.75 | 52-week low | $4.02 |
| Day low | $4.67 | Volume | 8,000 |
| Day high | $4.97 | Avg. volume | 20,466 |
| 50-day MA | $5.05 | Dividend yield | 17.39% |
| 200-day MA | $5.97 | Market Cap | 5.06M |
MDGS Stock Price Chart Interactive Chart >
MDGS Stock Summary
- With a price/sales ratio of 0.09, MEDIGUS LTD has a higher such ratio than just 2.01% of stocks in our set.
- With a year-over-year growth in debt of 9,371.96%, MEDIGUS LTD's debt growth rate surpasses 99.83% of about US stocks.
- As for revenue growth, note that MDGS's revenue has grown 17,199.06% over the past 12 months; that beats the revenue growth of 99.83% of US companies in our set.
- Stocks with similar financial metrics, market capitalization, and price volatility to MEDIGUS LTD are COLB, SWVL, DRIO, BTAI, and NUTX.
- MDGS's SEC filings can be seen here. And to visit MEDIGUS LTD's official web site, go to www.medigus.com.
MDGS Valuation Summary
- In comparison to the median Healthcare stock, MDGS's price/earnings ratio is 103.73% lower, now standing at -0.9.
- MDGS's price/sales ratio has moved down 42.1 over the prior 95 months.
Below are key valuation metrics over time for MDGS.
| Stock | Date | P/S | P/B | P/E | EV/EBIT |
|---|---|---|---|---|---|
| MDGS | 2023-05-23 | 0.1 | 0.2 | -0.9 | 0.2 |
| MDGS | 2023-05-22 | 0.1 | 0.2 | -0.9 | 0.1 |
| MDGS | 2023-05-19 | 0.1 | 0.2 | -0.9 | 0.1 |
| MDGS | 2023-05-18 | 0.1 | 0.2 | -1.0 | 0.1 |
| MDGS | 2023-05-17 | 0.1 | 0.2 | -0.9 | 0.1 |
| MDGS | 2023-05-16 | 0.1 | 0.3 | -1.0 | 0.0 |
MDGS Growth Metrics
- Its 5 year price growth rate is now at -83.65%.
- Its 5 year revenue growth rate is now at -49.63%.
- The 2 year net cashflow from operations growth rate now stands at -35.2%.
The table below shows MDGS's growth in key financial areas (numbers in millions of US dollars).
| Date | Revenue | Operating Cash Flow | Net Income to Common Stock |
|---|---|---|---|
| 2022-06-30 | 69.695 | -4.936 | -8.629 |
| 2021-12-31 | 10.118 | -5.25 | 4.046 |
| 2021-06-30 | 2.851 | -5.462 | 8.013 |
| 2020-12-31 | 0.531 | -6.143 | -4.325 |
| 2020-06-30 | 0.202 | -3.651 | -14.927 |
| 2019-12-31 | 0.273 | -2.757 | -14.178 |
MDGS's Quality Factors
The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.- MDGS has a Quality Grade of F, ranking ahead of 2.24% of graded US stocks.
- MDGS's asset turnover comes in at 0.023 -- ranking 164th of 186 Medical Equipment stocks.
- 500 - Internal server error
The table below shows MDGS's key quality metrics over time.
| Period | Asset Turnover | Gross Margin | ROIC |
|---|---|---|---|
| 2020-12-31 | 0.023 | -0.947 | -1.494 |
| 2019-12-31 | 0.022 | -0.667 | -12.213 |
| 2018-12-31 | 0.047 | -0.392 | -4.972 |
| 2017-12-31 | 0.078 | -0.105 | -1.353 |
| 2016-12-31 | 0.065 | 0.679 | -60.057 |
| 2015-12-31 | 0.047 | 0.556 | -8.106 |
Medigus Ltd. (MDGS) Company Bio
Medigus Ltd. develops endoscopic procedures and devices for the treatment of gastroesophageal reflux disease.
Latest MDGS News From Around the Web
Below are the latest news stories about MEDIGUS LTD that investors may wish to consider to help them evaluate MDGS as an investment opportunity.
Medigus Sells its Entire Stake in ScoutCam for Approximately $6 Million in CashTel Aviv, Israel, June 06, 2023 (GLOBE NEWSWIRE) -- Medigus Ltd. (Nasdaq: MDGS) (“Medigus”), a technology company engaged in advanced medical solutions, innovative internet technologies and electric vehicle (“EV”) and charging solutions, today announced that it has sold its entire stake in ScoutCam Inc. (OTCQB: SCTC), a leading provider of Predictive Maintenance (PdM) and Condition Based Monitoring (CBM) solutions. The Company has sold its holdings to existing shareholders and office holders in |
Medigus: Viewbix Reports Revenues of $20.9 Million in The First Quarter of 2023Viewbix, together with its subsidiaries, reached EBITDA of $658 thousand Tel Aviv, Israel, May 16, 2023 (GLOBE NEWSWIRE) -- Medigus Ltd. (Nasdaq: MDGS), a technology company engaged in advanced medical solutions, innovative internet technologies and electric vehicle and charging solutions, announced today that Viewbix Inc (henceforth “Viewbix”) (OTC: VBIX), 76% owned by Medigus’ subsidiary Gix Internet, (henceforth “Gix”) (42.25% owned by Medigus) (TASE: GIX), a global marketing technology (MarT |
Medigus Full Year 2022 Earnings: US$6.04 loss per share (vs US$4.42 profit in FY 2021)Medigus ( NASDAQ:MDGS ) Full Year 2022 Results Key Financial Results Revenue: US$91.9m (up by US$81.7m from FY 2021... |
Medigus Announces Record 2022 Financial ResultsRecord Revenues of approx. $92 million, up over 800% Y-o-YTEL AVIV, Israel, May 04, 2023 (GLOBE NEWSWIRE) -- Medigus Ltd. (Nasdaq: MDGS) (“Medigus”), a technology company engaged in advanced medical solutions, innovative internet technologies and electric vehicle and charging solutions, today announced financial results and the filing of its annual report on Form 20-F for the year ended December 31 2022, with the U.S. Securities and Exchange Commission (SEC). The annual report on Form 20-F, cont |
Medigus: Charging Robotics' AI Based Solution Ranked Among Top Outstanding Techpreneurs at the 14th Innovation World CupThe competition is in partnership with Industry giants like STMicroelectronics, EBV Elektronik, Würth Elektronik, VARTA Microbattery Tel Aviv, Israel, April 27, 2023 (GLOBE NEWSWIRE) -- Medigus Ltd. (Nasdaq: MDGS), a technology company engaged in electric vehicle charging solutions, advanced medical solutions, and innovative internet technologies, today announced that Charging Robotics Ltd., a subsidiary of Fuel Doctor Holdings, Inc., (“FDOC”) a Delaware corporation quoted on the OTC Market (60% |
MDGS Price Returns
| 1-mo | -26.94% |
| 3-mo | 9.59% |
| 6-mo | -12.89% |
| 1-year | -56.13% |
| 3-year | -83.89% |
| 5-year | -93.21% |
| YTD | 2.78% |
| 2022 | -64.57% |
| 2021 | -47.64% |
| 2020 | 9.77% |
| 2019 | -33.08% |
| 2018 | -50.76% |
MDGS Dividends
| Ex-Dividend Date | Type | Payout Amount | Change | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
Continue Researching MDGS
Want to do more research on Medigus Ltd's stock and its price? Try the links below:Medigus Ltd (MDGS) Stock Price | Nasdaq
Medigus Ltd (MDGS) Stock Quote, History and News - Yahoo Finance
Medigus Ltd (MDGS) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...